What Is The Current and Historic Market Size Analysis Of The Rabies Diagnostics Market?
The rabies diagnostics market has seen considerable growth due to a variety of factors.
• The market size for rabies diagnostics has seen robust growth over recent times. It is projected to expand from $1.68 billion in 2024 to $1.78 billion in 2025, marking a compound annual growth rate (CAGR) of 5.6%. The growth during the historical period can be traced back to factors such as globalization and travel trends, adoption of a holistic health approach, development of regulatory standards, progress in animal testing methods, and environmental factors.
What Is The Forecast For The Rabies Diagnostics Market Size In The Coming Years?
The Rabies Diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the rabies diagnostics market is anticipated to experience robust expansion, reaching $2.31 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%.
This growth predicted during the forecast period is due to factors such as the rise in rabies cases, environmental implications, cost-effectiveness, research and development, and surveillance requirements. Notable trends during this forecast period encompass government schemes and immunization programs, globalization coupled with travel, the one health approach, concerns regarding public health, as well as remote and point-of-care diagnostics.
What Are The Essential Drivers Behind The Growth Of The Rabies Diagnostics Market?
The market for rabies diagnostics is likely to be propelled by the escalating incidence of rabies. Rabies, a viral disease that can be prevented, is typically transmitted through a bite from an infected animal. It targets the central nervous system of mammals, leading to brain damage and eventual death. Various diagnostic tests and methods are used in the diagnosis of rabies in humans and animals. Moreover, the growing instances of infectious diseases transmitted by animals have boosted the need for rabies diagnostics. For example, a report from the Government of Canada, a federal Canadian authority, stated that in January 2023, 135 rabies samples were submitted in October 2022 and 159 rabies samples in November 2022. Consequently, the rising incidence of rabies is set to fuel the market for rabies diagnostics.
How Is The Global Rabies Diagnostics Market Divided Into Key Segments?
The rabies diagnostics market covered in this report is segmented –
1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
2) By Technology: ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
3) By End-User: Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
Subsegments:
1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA): Western Blotting
3) By Amplification Methods: Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
4) By Histologic Examination: Microscopic Examination, Tissue Staining Techniques
5) By Serology Tests: Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)
Pre-Book The Rabies Diagnostics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Rabies Diagnostics Market?
In the rabies diagnostics market, product innovation is becoming a key trend. Pharmaceutical manufacturers worldwide are embracing new and efficient testing methods developed in the realm of analytical chemistry, aimed at delivering precise and affordable analytical solutions. These products are seamlessly incorporated into routine sample analysis procedures. For example, Bio-Rad Laboratories Inc., a US-based company that specializes in technology products, launched the CFX Duet Real-Time PCR system in May 2022. This clinical diagnostic apparatus assists researchers in the creation of singleplex and duplex quantitative PCR (qPCR) tests. The product's distinctive attributes include enhanced thermal performance and a patented, precise optical shuttle system, in addition to thermal gradient functionality for optimization.
Who Are the Key Players In The Rabies Diagnostics Market?
Major companies operating in the rabies diagnostics market include:
• Bio-Rad Laboratories Inc.
• The Merck Group
• Aviva Systems Biology Corporation
• Creative Diagnostics
• Demeditec Diagnostics GmbH
• Abbexa Ltd.
• Norgen Biotek Corp.
• BioNote Inc.
• Express Biotech International Inc.
• MyBioSource Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies Inc.
• Fluidigm Corp.
• Bio-X Diagnostics S.A.
• Fujirebio Diagnostics Inc.
• Gold Standard Diagnostics Corp.
• Heska Corporation
• IDEXX Laboratories Inc.
• InBios International Inc.
• KHB Shanghai Kehua Bio-Engineering Co. Ltd.
• Meridian Bioscience Inc.
• MP Biomedicals LLC
• Neogen Corporation
• Randox Laboratories Ltd.
• SDIX LLC
• Sigma-Aldrich Corporation
• Virbac Animal health Pvt. Ltd.
• Zoetis Inc.
What Are The Regional Insights Into The Rabies Diagnostics Market?
North America was the largest region in the rabies diagnostics market in 2024. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
